ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 140 filers reported holding ATARA BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,776,000 | +10.3% | 1,200,000 | +20.0% | 0.14% | +19.0% |
| Q2 2023 | $1,610,000 | -67.2% | 1,000,000 | -23.1% | 0.12% | -69.5% |
| Q3 2022 | $4,914,000 | -69.2% | 1,300,000 | -36.4% | 0.38% | -66.2% |
| Q2 2022 | $15,930,000 | -6.3% | 2,045,000 | +11.7% | 1.12% | +23.6% |
| Q1 2022 | $17,001,000 | -39.4% | 1,830,000 | +2.7% | 0.91% | -11.9% |
| Q4 2021 | $28,073,000 | -12.0% | 1,781,234 | 0.0% | 1.03% | -17.0% |
| Q3 2021 | $31,885,000 | +202.6% | 1,781,234 | +162.8% | 1.24% | +241.8% |
| Q2 2021 | $10,538,000 | +232.3% | 677,683 | +206.9% | 0.36% | +116.7% |
| Q1 2021 | $3,171,000 | -26.9% | 220,848 | 0.0% | 0.17% | -18.0% |
| Q4 2020 | $4,335,000 | +51.5% | 220,848 | 0.0% | 0.20% | -2.4% |
| Q3 2020 | $2,862,000 | -11.1% | 220,848 | 0.0% | 0.21% | -18.6% |
| Q2 2020 | $3,218,000 | +681.1% | 220,848 | +783.4% | 0.26% | +448.9% |
| Q4 2019 | $412,000 | – | 25,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XV Associates, LLC | 1,876,650 | $29,182,000 | 13.03% |
| Copernicus Capital Management, LLC | 50,000 | $778,000 | 12.27% |
| Antipodean Advisors LLC | 1,000,000 | $15,550,000 | 4.28% |
| BRIDGER MANAGEMENT, LLC | 1,325,188 | $20,607,000 | 1.92% |
| Redmile Group, LLC | 6,449,577 | $100,291,000 | 1.48% |
| MAVERICK CAPITAL LTD | 7,704,676 | $119,808,000 | 1.12% |
| Baupost Group | 8,477,488 | $131,825,000 | 1.07% |
| ACT CAPITAL MANAGEMENT, LLC | 116,900 | $1,818,000 | 0.93% |
| Trellus Management Company, LLC | 73,056 | $1,136,000 | 0.78% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $8,164,000 | 0.75% |